Prova Storytel gratis i 30 dagar Ett universum fyllt av ljudböcker, klicka här för att komma igång

The BioInsights Podcast

En podcast av: BioInsights

The BioInsights Podcast: discussing the challenges of translating novel biologics from bench to clinic to market.

Our english speaking users can also listen to The BioInsights Podcast on our english site

55 Avsnitt

The promise of antibody-oligonucleotide conjugates for neurological diseases
Publicerades 2025-08-27

From innovation to access: bridging gaps in scalability and cold chain precision logistics for advanced therapies
Publicerades 2025-07-18
Enhancing mRNA results through strategic RNA design and quality control
Publicerades 2025-03-27
For the many and the few: bringing ASO therapies to both mainstream and nano-rare indications
Publicerades 2025-03-13
Exploring challenges, opportunities and state-of-the-art tools in the lipid nanoparticle space
Publicerades 2025-02-19
Driving innovation in cell and gene therapy: the role of AI and robotics
Publicerades 2025-01-27
Spatial mapping: shaping the future of I-O diagnostics and treatment
Publicerades 2024-12-06
Pioneering quality control in biomanufacturing of cell and gene therapies
Publicerades 2024-12-05
Preparing for tomorrow’s cell and gene therapies today: lessons from 30 years in the field
Publicerades 2024-09-06
Insights into advanced therapies in the context of evolving funding and M&A environments
Publicerades 2024-06-14
Fit for function: developing potency assays reflective of the in vivo environment
Publicerades 2024-05-10
Gene therapy is having a monumental year: how can the industry keep up with supply?
Publicerades 2024-04-04
A deep dive in to generative AI applications in I-O
Publicerades 2024-03-18
Developing novel radioimmunotherapy combinations for lung cancer treatment
Publicerades 2024-03-12
Focusing on the fundamentals: what do and don’t we know about mRNA delivery?
Publicerades 2024-03-11
Navigating genomics and transcriptomics in the immuno-oncology space
Publicerades 2024-03-01
Avian influenza and the risk of pandemic
Publicerades 2024-02-27
Exploring the landscape of novel targets & pathways in immuno-oncology
Publicerades 2023-12-04
Multiomics integration: advancing pediatric cancer immunotherapy
Publicerades 2023-11-02
Building with the patient in mind: designing a state-of-the-art facility for viral vector manufacturing
Publicerades 2023-10-10

The BioInsights Podcast: discussing the challenges of translating novel biologics from bench to clinic to market.

55 Avsnitt

The promise of antibody-oligonucleotide conjugates for neurological diseases

From innovation to access: bridging gaps in scalability and cold chain precision logistics for advanced therapies

Enhancing mRNA results through strategic RNA design and quality control

For the many and the few: bringing ASO therapies to both mainstream and nano-rare indications

Exploring challenges, opportunities and state-of-the-art tools in the lipid nanoparticle space

Driving innovation in cell and gene therapy: the role of AI and robotics

Spatial mapping: shaping the future of I-O diagnostics and treatment

Pioneering quality control in biomanufacturing of cell and gene therapies

Preparing for tomorrow’s cell and gene therapies today: lessons from 30 years in the field

Insights into advanced therapies in the context of evolving funding and M&A environments

Fit for function: developing potency assays reflective of the in vivo environment

Gene therapy is having a monumental year: how can the industry keep up with supply?

A deep dive in to generative AI applications in I-O

Developing novel radioimmunotherapy combinations for lung cancer treatment

Focusing on the fundamentals: what do and don’t we know about mRNA delivery?

Navigating genomics and transcriptomics in the immuno-oncology space

Avian influenza and the risk of pandemic

Exploring the landscape of novel targets & pathways in immuno-oncology

Multiomics integration: advancing pediatric cancer immunotherapy

Building with the patient in mind: designing a state-of-the-art facility for viral vector manufacturing